Skip to main content Accessibility help
×
Home

Mucosal Barrier Injury Central-Line–Associated Bloodstream Infections: What is the Impact of Standard Prevention Bundles?

  • Ana M. Vaughan (a1), Rachael Ross (a1), Margaret M. Gilman (a2), Lauren Satchell (a2), Susan Ditaranto (a3), Anne F. Reilly (a4), Leslie S. Kersun (a5), Amanda Shanahan (a5), Susan E. Coffin (a1) and Julia Shaklee Sammons (a6)...
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Mucosal Barrier Injury Central-Line–Associated Bloodstream Infections: What is the Impact of Standard Prevention Bundles?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Mucosal Barrier Injury Central-Line–Associated Bloodstream Infections: What is the Impact of Standard Prevention Bundles?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Mucosal Barrier Injury Central-Line–Associated Bloodstream Infections: What is the Impact of Standard Prevention Bundles?
      Available formats
      ×

Abstract

Copyright

Corresponding author

Address correspondence to Julia Shaklee Sammons, MD, MSCE, Department of Infection Prevention and Control, The Children’s Hospital of Philadelphia, 3401 Civic Center Boulevard, A level – Room #AE20, Philadelphia, PA 19104 (sammonsj@email.chop.edu).

Footnotes

Hide All

PREVIOUS PRESENTATION. Part of these data were presented as a poster at IDWeek 2016 in New Orleans, Louisiana, on October 27, 2016, abstract #58502.

Footnotes

References

Hide All
1. Highlighted NHSN January 2013 Patient Safety Component (PSC) Manual updates. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/PDFs/Newsletters/January-2013-PSC-Updates.pdf. Published 2013. Accessed November 26, 2016.
2. 2016 National Healthcare Safety Network (NHSN) Patient Safety Component Manual. Centers for Disease Control and Prevention. https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf. Published 2016. Accessed November 26, 2016.
3. Epstein, L, See, I, Edwards, JR, Magill, SS, Thompson, ND. Mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBI): descriptive analysis of data reported to National Healthcare Safety Network (NHSN), 2013. Infect Control Hosp Epidemiol 2015;37:27.
4. See, I, Iwamoto, M, Allen-Bridson, K, Horan, T, Magill, SS, Thompson, ND. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new national healthcare safety network definition. Infect Control Hosp Epidemiol 2013;34:769776.
5. Metzger, KE, Rucker, Y, Callaghan, M, et al. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients. Infect Control Hosp Epidemiol 2015;36:119124.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed